Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction

Affiliations

¹ Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
² Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.
³ Department of Microbiology, Immunology and Tropical Medicine, Research Center for Neglected Diseases of Poverty, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
⁴ Department of Medicine, University of North Carolina HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
⁵ Ceres Nanosciences Inc., Manassas, VA, USA.
⁶ Departments of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁷ Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁸ Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁹ Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, USA.
¹⁰ Integrated BioTherapeutics, Inc., Gaithersburg, MD, USA.

Published Erratum

Michelle L Pleet et al. Front Microbiol. 2018.

. 2018 Apr 17:9:692.

doi: 10.3389/fmicb.2018.00692. eCollection 2018.

¹ Laboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, USA.
² Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA, USA.
³ Department of Microbiology, Immunology and Tropical Medicine, Research Center for Neglected Diseases of Poverty, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
⁴ Department of Medicine, University of North Carolina HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
⁵ Ceres Nanosciences Inc., Manassas, VA, USA.
⁶ Departments of Pathology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁷ Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁸ Galveston National Laboratory, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
⁹ Department of Medicine, Center for Sickle Cell Disease, Howard University, Washington, DC, USA.
¹⁰ Integrated BioTherapeutics, Inc., Gaithersburg, MD, USA.

Abstract

[This corrects the article on p. 1765 in vol. 7, PMID: 27872619.].

Keywords: EBOV; ESCRT; Ebola virus; VLP; VP40; apoptosis; exosomes; microRNA.

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.
Pleet ML, Mathiesen A, DeMarino C, Akpamagbo YA, Barclay RA, Schwab A, Iordanskiy S, Sampey GC, Lepene B, Nekhai S, Aman MJ, Kashanchi F. Pleet ML, et al. Front Microbiol. 2016 Nov 7;7:1765. doi: 10.3389/fmicb.2016.01765. eCollection 2016. Front Microbiol. 2016. PMID: 27872619 Free PMC article.

1. Ilinykh P. A., Tigabu B., Ivanov A., Ammosova T., Obukhov Y., Garron T., et al. . (2014). Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription. J. Biol. Chem. 289, 22723–22738. 10.1074/jbc.M114.575050 - DOI - PMC - PubMed